RE:RE:RE:ASCO relevance
Hello Geneman and good to see you back, we used to have some good conversations in the old days with you , bioeye, myself, proboscis, and rjc. I have hung around and endured the story forever hoping that one day they would come through and this time looks as good as any or actually better than their usual as there is a lot more to back it up at this time or so it seems. I do like that we basically received confirmation through the AN bridging trial although it was a small patient sampling but none the less similar results to the original trial. More later as the talks and thoughts progress.